Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.

Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (15)

    1. Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats 2026-10-01 · Expand citations
    2. Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz Waves 2026-09-12 · Expand citations
    3. Cardiovascular safety of psilocybin in psychiatric practice: a narrative review 2026-08-01 · Expand citations
    4. In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin 2026-08-01 · Expand citations
    5. Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms 2026-05-01 · Expand citations
    6. Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs 2026-03-18 · Expand citations
    7. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    8. Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications 2025-10-31 · Expand citations
    9. Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
    10. Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties 2025-04-10 · Expand citations
    11. Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα 2025-03-01 · Expand citations
    12. Mushroom bioactives-polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity 2025-01-01 · Expand citations
    13. In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin 2024-01-08 · Expand citations
    14. A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines 2023-09-09 · Expand citations
    15. Introduction to the chemistry and pharmacology of psychedelic drugs 2023-07-04 · Expand citations